Latest Retro Biosciences News & Updates

See the latest news and media coverage for Retro. We track all announcements, press releases, and industry mentions in real time, all in one place.

Retro Biosciences (Retro)

Developer of therapeutics targeting cellular aging

retro.bio

Headquarters: Redwood City, United States
Company type: Private company
Number of employees: 90–200

Last updated Today

Latest news about Retro Biosciences (Retro)

In short: Retro transitioned into a clinical-stage organization and secured significant financing to advance its mission of extending human healthspan.

Company announcements

May 22 Retro

Retro announces initial close of financing

The round values the company at $1.8 billion, led by 4P Capital, funding RTR242's clinical advancement and expansion of cell therapy, AI protein engineering, and manufacturing capabilities.

29 December 2025 Retro

Retro achieves First In Human milestone

Retro becomes a clinical stage company after reaching the clinic in Q4. The organization thanks teams and anticipates 2026.

22 August 2025 Retro

Retro Bio highlights collaboration with OpenAI on GPT-4b

The partnership focuses on using GPT-4b to engineer proteins that enhance stem cell reprogramming and accelerate their mission.

20 May 2025 Retro

Retro Bio announces collaboration with MCRI

The partnership aims to develop preventative medicine by rejuvenating the blood system using a person's genetics to extend healthy lifespan by 10 years.

Media coverage

June 3 MSN

Can AI stop humans from ageing? Sam Altman is betting millions on it

A fresh debate around AI, healthcare and the future of human ageing has exploded online after a viral X post by Ricardo, a private content...

April 13 Scientific American

This method to reverse cellular aging is about to be tested in humans

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

April 7 Nature

This method to reverse cellular ageing is about to be tested in humans

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely refresh aged tissues and organs.

30 December 2025 Longevity.Technology

Retro Bio commences first-in-human trial

Autophagy-enhancing drug candidate enters Phase 1 trial as longevity focused biotech eyes Alzheimer's as a potential first indication.

Never miss news about Retro

Track Retro and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Retro competitors & trending companies

Browse news for competitors to Retro and other trending companies.